Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Leyre Díaz de Cerio Julián"'
Autor:
Mercè Falip, Xiana Rodríguez-Osorio, Elena Fonseca, Paula Martínez Agredano, Jorge Zurita Santamaría, María Gómez-Eguilaz, María Rosa Querol-Pascual, José Carlos Estévez-María, Laura Abraira, José Angel Mauri Llerda, María Dolores Castro Vilanova, Leyre Díaz de Cerio Julián, Juan José Poza, Manuel Quintana, Pablo Quiroga-Subirana, Manuel Toledo, Iñigo Garamendi, Hernando Pérez Díaz, Jacint Sala-Padró, Maria Centeno, Estevo Santamarina, Dulce M. Campos Blanco, Iván Seijo-Raposo
Publikováno v:
Epilepsy & Behavior. 122:108127
To investigate the relationship between self-reported sleep quality and cognitive function in patients with epilepsy (PWE), as well as anxiety and depressive symptoms and patient quality of life (QoL).This multicenter cross-sectional study included P
Autor:
María Eugenia García-García, Iñigo Garamendi-Ruiz, Vicente Bertol-Alegre, Ainhoa Marinas-Alejo, Marta Agúndez-Sarasola, José Antonio Oliván-Usieto, A.B. Gago-Veiga, García-Gomara Mj, Sonia Santos-Lasaosa, Mauri-Llerda Ja, Juan Carlos Gómez-Esteban, Inés Escalza-Cortina, Carolina Arcos-Sánchez, Eliana Rueda-Mena, Vanesa Garayoa-Irigoyen, Leyre Díaz de Cerio Julián, Elena Muñoz-Fargas, Vanessa García-Morales, María De Toledo-Heras, Irene García-Morales
Publikováno v:
Epileptic Disorders. 18:173-180
Perampanel, a non-competitive antagonist of the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptors, is the most recent antiepileptic drug available in Spain, marketed in January 2014. It was initially approved by the European Medicines